Neutrophil-endothelial interactions mediate angiopoietin-2-associated pulmonary endothelial cell dysfunction in indirect acute lung injury in mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 1, 2014, Pages 193-200

  Lomas Neira, Joanne ^a   Venet, Fabienne ^b   Chung, Chun Shiang ^a   Thakkar, Rajan ^a   Heffernan, Daithi ^a   Ayala, Alfred ^a  

^a BROWN UNIVERSITY   (United States)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Angiopoietin 2; Endothelial cells; Indirect acute lung injury; Neutrophil; Short interference (si) RNA

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL FUNCTION; CELL ACTIVATION; CELL INTERACTION; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INDIRECT ACUTE LUNG INJURY; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MALE; MEDIATOR RELEASE; MIDDLE AGED; MOUSE; MURINE MODEL; NEUTROPHIL; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ACUTE LUNG INJURY; ANGIOPOIETIN-2; ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LUNG; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; SEPSIS; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891808520     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0148OC     Document Type: Article

References (43)

1. Minino A, Heron M, Smith B. Preliminary data for 2004. National Vital Statistics Reports. Atlanta, GA: CDC; 2004.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310. (Pubitemid 32641789)
3. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, Rotstein OD. Hemorrhagic shock primes for increased expression of cytokineinduced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol 1998;161: 440-447. (Pubitemid 28285553)
4. Abraham E, Carmody A, Shenkar R, Arcaroli J. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000;279: L1137-L1145. (Pubitemid 32009500)
5. Lomas-Neira J, Chung CS, Grutkoski PS, Dunican AL, Simms HH, Cioffi WG, Ayala A. Divergent roles of murine neutrophil chemokines in hemorrhage induced priming for acute lung injury. Cytokine 2005;31:169-179. (Pubitemid 40967900)
6. Lomas JL, Chung CS, Grutkoski PS, LeBlanc BW, Lavigne L, Reichner J, Gregory SH, Doughty LA, Cioffi WG, Ayala A. Differential effects of macrophage inflammatory chemokine-2 and keratinocyte-derived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: assessment by adoptive cells transfer in mice. Shock 2003;19:358-365.
7. Lomas-Neira J, Chung C-S, Perl M, Gregory S, Biffl W, Ayala A. Role of alveolar macrophage and migrating neutrophils in hemorrhageinduced priming for ALI subsequent to septic challenge. Am J Physiol Lung Cell Mol Physiol 2006;290:L51-L58.
8. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008;63:903-909.
9. Childs EW, Tharakan B, Byrge N, Tinsley JH, Hunter FA, Smythe WR. Angiopoietin-1 inhibits intrinsic apoptotic signaling and vascular hyperpermeability following hemorrhagic shock. Am J Physiol Heart Circ Physiol 2008;294:H2285-H2295.
10. Lentsch AB, Ward PA. Regulation of experimental lung inflammation. Respir Physiol 2001;128:17-22. (Pubitemid 32771688)
11. Maniatis NA, Orfanos SE. The endothelium in acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2008;14:22-30.
12. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006;12:1286-1293. (Pubitemid 44706931)
13. Parikh SM, Mammoto T, Schultz A, Yuan H-T, Christiani D, Karumanchi SA, Sukhatme VP. Express circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Medicine 2006;3:0356-0370.
14. Ganter MT, Cohen MJ, Brohi K, Chesebro BB, Staudenmayer KL, Rahn P, Christiaans SC, Bir ND, Pittet J-F. Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ann Surg 2008;247:320-326. (Pubitemid 351156777)
15. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70-74.
16. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60. (Pubitemid 27450643)
17. Lemieux C, Maliba R, Favier J, Thé oret J-F, Merhi Y, Sirois MG. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2005;105:1523-1530. (Pubitemid 40223669)
18. Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AIM, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 2001;49:659-670. (Pubitemid 32146429)
19. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 2002;3:411-423.
20. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-1180. (Pubitemid 27010101)
21. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999;286: 2511-2514.
22. Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J, Ioffe E, Daly TJ, Fandl JP, Papadopoulos N, et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 2006;103:15491-15496. (Pubitemid 44625619)
23. Hegen A, Koidl S, Weindel K, Marmé D, Augustin HG, Fiedler U. Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements. Arterioscler Thromb Vasc Biol 2004;24:1803-1809. (Pubitemid 39350295)
24. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 2005;118:771-780. (Pubitemid 40372585)
25. Tsigkos S, Zhou Z, Kotanidou A, Fulton D, Zakynthinos S, Roussos C, Papapetropoulos A. Regulation of Ang2 release by PTEN/PI3-kinase/ Akt in lung microvascular endothelial cells. J Cell Physiol 2006;207: 506-511.
26. Augustin HG, Kozian DH, Johnson RC. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 1994;16:901-906. (Pubitemid 24974469)
27. McCarter SD, Mei SHJ, Lai PFH, Zhang QW, Parker CH, Suen RS, Hood RD, Zhao YD, Deng Y, Han RNN, et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 2007;175:1014-1026. (Pubitemid 46741753)
28. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007; 35:199-206. (Pubitemid 46035696)
29. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.Am J Respir Crit Care Med 1994;149:818-824. (Pubitemid 24082248)
30. Lomas-Neira J, Perl M, Venet F, Chung CS, Ayala A. The role and source of tumor necrosis factor-a in hemorrhage-induced priming for septic lung injury. Shock 2012;37:611-620.
31. Wenxin L, Jinxiang F, Yong W, Wenxiang L, Wenbiao S, Xueguang Z. Expression of membrane-bound IL-15 by bone marrow fibroblastlike stromal cells in aplastic anemia. Int Immunol 2005;17:429-437. (Pubitemid 40568118)
32. Wang H, Su Z, Schwarze J. Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation. Thorax 2009;64:283-290.
33. Su W, Fan H, Chen M, Wang J, Brand D, He X, Quesniaux V, Ryffel B, Zhu L, Liang D, et al. Induced CD41 forkhead box protein-positive T cells inhibit mast cell function and established contact hypersensitivity through TGF-b1. J Allergy Clin Immunol 2012;130: 444-452, e7.
34. Wesche-Soldato DE, Chung CS, Gregory SH, Salazar-Mather TP, Ayala CA, Ayala A. CD81 T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL. Am J Pathol 2007;171:87-96. (Pubitemid 47339229)
35. Wesche-Soldato DE, Chung CS, Lomas-Neira J, Doughty LA, Gregory SH, Ayala A. In vivo delivery of caspase 8 or Fas siRNA improves the survival of septic mice. Blood 2005;106:2295-2301. (Pubitemid 41510799)
36. Grutkoski PS, Chen Y, Chung CS, Ayala A. Sepsis-induced SOCS-3 expression is immunologically restricted to phagocytes. J Leukoc Biol 2003;74:916-922. (Pubitemid 38040368)
37. Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG. The Tie-2 ligand angiopoietin- 2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004;103:4150-4156. (Pubitemid 38685356)
38. Santel A, Aleku M, Keil O, Endruschat J, Esche V, Fisch G, Dames S, L̈offler K, Fechtner M, Arnold W, et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther 2006;13:1222-1234. (Pubitemid 44184716)
39. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000;6: 460-463. (Pubitemid 30208166)
40. Ganta VC, Cromer W, Mills GL, Traylor J, Jennings M, Daley S, Clark B, Mathis JM, Bernas M, Boktor M, et al. Angiopoietin-2 in experimental colitis. Inflamm Bowel Dis 2010;16:1029-1039.
41. Nag S, Papneja T, Venugopalan R, Stewart DJ. Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown. Lab Invest 2005;85:1189-1198. (Pubitemid 41348635)
42. Shapiro NI, Schuetz P, Yano K, Sorasaki M, Parikh SM, Jones AE, Trzeciak S, Ngo L, Aird WC. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010;14:R182.
43. Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Matsumoto T, Maeshima A, Hiromura K, Nojima Y. Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis. Rheumatology 2012;51: 1571-1579.